Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
63,121
-
Shares change
-
-67,760
-
Total reported value, excl. options
-
$688,650
-
Value change
-
-$739,261
-
Number of sells
-
1
-
Price
-
$10.91
Institutional Holders of PROTAGONIST THERAPEUTICS INC - COM as of Q4 2022
As of 31 Dec 2022 PROTAGONIST THERAPEUTICS INC - COM had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 63,121 shares of stock of the company.
Largest 1 holders included Twin Lakes Capital Management, LLC.
This table shows 1 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.